These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12804860)

  • 1. Differences in immunogenicity and vaccine potential of peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase.
    Tallima H; Montash M; Veprek P; Velek J; Jezek J; El Ridi R
    Vaccine; 2003 Jul; 21(23):3290-300. PubMed ID: 12804860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and vaccine potential of dipeptidic multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase.
    El Ridi R; Montash M; Tallima H
    Scand J Immunol; 2004 Oct; 60(4):392-402. PubMed ID: 15379864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human and murine humoral immune recognition of multiple peptides from Schistosoma mansoni glyceraldehyde 3-P dehydrogenase is associated with resistance to Schistosomiasis.
    El Ridi R; Mahrous A; Afifi A; Montash M; Velek J; Jezek J
    Scand J Immunol; 2001 Nov; 54(5):477-85. PubMed ID: 11696199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptides and multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase: preparation, immunogenicity and immunoprotective capacity in C57BL/6 mice.
    Veprek P; Jezek J; Velek J; Tallima H; Montash M; El Ridi R
    J Pept Sci; 2004 Jun; 10(6):350-62. PubMed ID: 15214440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase.
    Tallima H; Dvořák J; Kareem S; Abou El Dahab M; Abdel Aziz N; Dalton JP; El Ridi R
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005443. PubMed ID: 28346516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential protective impact of peptide vaccine formulae targeting the lung- and liver-stage of challenge Schistosoma mansoni infection in mice.
    Tallima H; Tadros MM; El Ridi R
    Acta Trop; 2024 Jun; 254():107208. PubMed ID: 38621620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T- and B-cell responses to Schistosoma mansoni recombinant glyceraldehyde 3-phosphate dehydrogenase correlate with resistance to reinfection with S. mansoni or Schistosoma haematobium after chemotherapy.
    El Ridi R; Shoemaker CB; Farouk F; El Sherif NH; Afifi A
    Infect Immun; 2001 Jan; 69(1):237-44. PubMed ID: 11119511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R; Tallima H
    Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses in mice after immunization with antigens from different stages of the parasite Schistosoma mansoni.
    Gaber HM; Maghraby AS; Ahmed MB; Ruppel A; Bahgat MM
    Z Naturforsch C J Biosci; 2010; 65(3-4):289-302. PubMed ID: 20469651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection.
    Da'Dara AA; Skelly PJ; Walker CM; Harn DA
    Parasite Immunol; 2003; 25(8-9):429-37. PubMed ID: 14651590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity.
    El Ridi R; Tallima H; Selim S; Donnelly S; Cotton S; Gonzales Santana B; Dalton JP
    PLoS One; 2014; 9(1):e85401. PubMed ID: 24465551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T and B cell reactivity to a 42-kDa protein is associated with human resistance to both schistosomiasis mansoni and haematobium.
    El Ridi R; Farouk F; Sherif M; Al-Sherbiny M; Osman A; El Gengehi N; Shoemaker CB
    J Infect Dis; 1998 May; 177(5):1364-72. PubMed ID: 9593026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Egg-hatching inhibition in mice immunized with recombinant Schistosoma bovis 28 kDa glutathione S-transferase.
    Da Costa AV; Gaubert S; Lafitte S; Fontaine J; Capron A; Grzych JM
    Parasite Immunol; 1999 Jul; 21(7):341-50. PubMed ID: 10417668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of the Schistosoma mansoni nucleic acid vaccine, Sm23, following microseeding or gene gun delivery.
    Da'dara AA; Skelly PJ; Fatakdawala M; Visovatti S; Eriksson E; Harn DA
    Parasite Immunol; 2002 Apr; 24(4):179-87. PubMed ID: 12010483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to the fucosylated LacdiNAc glycan antigen in Schistosoma mansoni-infected mice and expression of the glycan among schistosomes.
    Nyame AK; Leppänen AM; Bogitsh BJ; Cummings RD
    Exp Parasitol; 2000 Dec; 96(4):202-12. PubMed ID: 11162373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of adult worm and lung-stage antigens to immunize against Schistosoma mansoni using cytokines as adjuvants.
    Afifi MA; El-Wakil HS; Abdel-Ghaffar MM; Mohamed RT
    J Egypt Soc Parasitol; 2006 Apr; 36(1):351-62, 2p following 362. PubMed ID: 16605124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.
    Ricciardi A; Dalton JP; Ndao M
    Vaccine; 2015 Jan; 33(2):346-53. PubMed ID: 25448114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines.
    El Ridi R; Tallima H
    J Parasitol; 2013 Apr; 99(2):194-202. PubMed ID: 22985345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of a protective peptide-based vaccine against Schistosoma mansoni.
    Tarrab-Hazdai R; Schechtman D; Arnon R
    Infect Immun; 1998 Sep; 66(9):4526-30. PubMed ID: 9712813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice.
    Preyavichyapugdee N; Sahaphong S; Riengrojpitak S; Grams R; Viyanant V; Sobhon P
    Exp Parasitol; 2008 Jun; 119(2):229-37. PubMed ID: 18329021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.